-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/clinician
December 01, 2019 - Presenting symptoms, a physical examination, a prostate-specific antigen (PSA) test, and a biopsy may … and then intervening to manage them. 3 WW does not include active monitoring such as performing a PSA … Active surveillance (AS)
A strategy with curative intent that involves regular monitoring of PSA … Physicians might take into consideration age, general health status, stage of tumor, PSA level, Gleason … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_espanol.pdf
November 01, 2016 - � Examen de sangre para antígeno prostático específico (PSA,
en inglés): Este análisis de sangre … indica cuánto PSA (una
proteína elaborada por la próstata) circula en la sangre. … En
muchos casos de cáncer de próstata, el nivel de PSA es mayor
de lo normal o ha aumentado con el … ☐ Un nivel alto de PSA no siempre significa que el hombre
tenga cáncer de próstata. … Este
agrandamiento y otros problemas de salud pueden causar
un nivel alto de PSA en hombres que no
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_espanol.pdf
November 01, 2016 - � Examen de sangre para antígeno prostático específico (PSA,
en inglés): Este análisis de sangre … indica cuánto PSA (una
proteína elaborada por la próstata) circula en la sangre. … En
muchos casos de cáncer de próstata, el nivel de PSA es mayor
de lo normal o ha aumentado con el … ☐ Un nivel alto de PSA no siempre significa que el hombre
tenga cáncer de próstata. … Este
agrandamiento y otros problemas de salud pueden causar
un nivel alto de PSA en hombres que no
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/espanol
May 01, 2020 - Examen de sangre para antígeno prostático específico (PSA, en inglés): Este análisis de sangre indica … cuánto PSA (una proteína elaborada por la próstata) circula en la sangre. … Un nivel alto de PSA no siempre significa que el hombre tenga cáncer de próstata. … Su médico puede utilizar su nivel de PSA, el puntaje de Gleason y el puntaje tumoral (puntaje T) para … El cáncer se descubre en una biopsia efectuada después que un hombre presenta un nivel alto de PSA o
-
effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/09.html
June 08, 2018 - Your PSA number, Gleason Score, and T stage will help you and your doctor choose the next best step in … If you know it, enter your PSA number here:
If you know it, enter your Gleason Score here:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
December 06, 2010 - Background and Objectives for the Systematic Review
Psoriatic arthritis (PsA) is among the most disabling … PsA has a highly variable
presentation, which generally involves pain and inflammation in joints and … Additionally, PsA may
predate the development of skin disease leading to some diagnostic uncertainty … In the general
population the prevalence of PsA is estimated to be 0.3% to 1%. … The oral DMARDs used to treat patients with PsA are
hydrochloroquine, leflunomide, methotrexate, and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
December 06, 2010 - Background and Objectives for the Systematic Review
Psoriatic arthritis (PsA) is among the most disabling … PsA has a highly variable
presentation, which generally involves pain and inflammation in joints and … Additionally, PsA may
predate the development of skin disease leading to some diagnostic uncertainty … In the general
population the prevalence of PsA is estimated to be 0.3% to 1%. … The oral DMARDs used to treat patients with PsA are
hydrochloroquine, leflunomide, methotrexate, and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - , reported as a ratio of
free to total PSA or percent free PSA (%fPSA). … • A second isoform is PSA bound to serum antiproteases,
or complexed PSA (cPSA). … • PSA density is the ratio of tPSA concentration to
prostate volume. … Utility of PSA velocity
for predicting positive biopsy or insignificant cancer is
not clear.17 PSA … • How does PCA3 compare with the two more frequently
used add-on tests (free PSA, PSA velocity) that
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - , reported as a ratio of
free to total PSA or percent free PSA (%fPSA). … • A second isoform is PSA bound to serum antiproteases,
or complexed PSA (cPSA). … • PSA density is the ratio of tPSA concentration to
prostate volume. … Utility of PSA velocity
for predicting positive biopsy or insignificant cancer is
not clear.17 PSA … • How does PCA3 compare with the two more frequently
used add-on tests (free PSA, PSA velocity) that
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-surveillance/research
December 01, 2019 - Increased diagnosis of early-stage prostate cancer due to prostate-specific antigen (PSA) testing, led … Currently, patients are diagnosed with earlier stage and lower risk prostate cancers compared to the pre-PSA … different monitoring protocols, all with different combinations of periodic digital rectal examination, PSA … included older age, presence of comorbidities, lower Gleason score, lower tumor stage, lower diagnostic PSA
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
December 29, 2015 - and a monoclonal antibody for treating
either ankylosing spondylitis (AS) or psoriatic arthritis (PsA … The main symptoms
of PsA are joint pain, stiffness, and swelling that can affect any joint. … Severe PsA will develop in a small
proportion of patients, appearing in their hands, feet, and spine … By blocking the effects of IL-17A–localized
autoimmune reactions, PsA symptoms may be limited while … Five phase III trials on secukinumab for treating PsA are ongoing.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
December 29, 2015 - and a monoclonal antibody for treating
either ankylosing spondylitis (AS) or psoriatic arthritis (PsA … The main symptoms
of PsA are joint pain, stiffness, and swelling that can affect any joint. … Severe PsA will develop in a small
proportion of patients, appearing in their hands, feet, and spine … By blocking the effects of IL-17A–localized
autoimmune reactions, PsA symptoms may be limited while … Five phase III trials on secukinumab for treating PsA are ongoing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Psoriatic
arthritis (PsA) affects fewer people than
RA (approximately 1 million people in the
United … PsA is associated with the
skin disease psoriasis. … Like RA, PsA can be disabling. … Treatment of patients with RA and PsA
aims to control pain and inflammation and,
ultimately, to slow … Historically, few trials have been conducted on patients
with PsA, with only minimal research conducted
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Psoriatic
arthritis (PsA) affects fewer people than
RA (approximately 1 million people in the
United … PsA is associated with the
skin disease psoriasis. … Like RA, PsA can be disabling. … Treatment of patients with RA and PsA
aims to control pain and inflammation and,
ultimately, to slow … Historically, few trials have been conducted on patients
with PsA, with only minimal research conducted
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
April 01, 2013 - PSA and beyond: the
past, present, and future of investigative
biomarkers for prostate cancer. … , PSA velocity) that have appeared in guidance
documents … , PSA velocity, nomograms etc. … /PSA velocity) and time to progression. … The combination of
urine DD3(PCA3) mRNA and PSA mRNA as molecular markers
of prostate cancer.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
April 01, 2013 - PSA and beyond: the
past, present, and future of investigative
biomarkers for prostate cancer. … , PSA velocity) that have appeared in guidance
documents … , PSA velocity, nomograms etc. … /PSA velocity) and time to progression. … The combination of
urine DD3(PCA3) mRNA and PSA mRNA as molecular markers
of prostate cancer.
-
psnet.ahrq.gov/node/49518/psn-pdf
August 01, 2006 - list_uids=9250229
http://www.ismp.org/newsletters/acutecare/archives/nov02.asp
http://www.psa.state.pa.us/psa … /lib/psa/advisories/pa-psrs_supplementary_advisory_v1_s1.pdf
http://www.psa.state.pa.us/psa/lib/psa … View AHRQ Disclaimers
http://www.psa.state.pa.us/psa/lib/psa/advisories/pa-psrs_supplementary_advisory_v1
-
effectivehealthcare-admin.ahrq.gov/health-topics/prostate-cancer-screening
Another test is the prostate-specific antigen (PSA) blood test. … Your PSA level may be high if you have prostate cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
May 19, 2011 - Currently, most prostate cancer in men in the United States is found by prostate-specific
antigen (PSA … Active surveillance is a fairly involved followup of patients—by monitoring PSA levels
and sometimes … PSA
c. Diagnostic Strategies
i. Biopsy frequency
ii. Number of cores
iii. … PSA (velocity, doubling time)
vi. Imaging
vii. Behavioral indicators
b. … PSA
v. Imaging
vi.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
May 19, 2011 - Currently, most prostate cancer in men in the United States is found by prostate-specific
antigen (PSA … Active surveillance is a fairly involved followup of patients—by monitoring PSA levels
and sometimes … PSA
c. Diagnostic Strategies
i. Biopsy frequency
ii. Number of cores
iii. … PSA (velocity, doubling time)
vi. Imaging
vii. Behavioral indicators
b. … PSA
v. Imaging
vi.